| P50 | author | Liwen Feng | Q92320389 |
| | Wei Fan | Q92320393 |
| P2093 | author name string | Hui Jiang | |
| | Kailai Nie | |
| P2860 | cites work | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement | Q21195843 |
| | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 |
| | Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration | Q28240096 |
| | Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan | Q28245638 |
| | Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease | Q30693939 |
| | Studies on the singlet oxygen scavenging mechanism of human macular pigment | Q34129179 |
| | Lutein: more than just a filter for blue light | Q34215851 |
| | Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. | Q34315578 |
| | Role of lutein supplementation in the management of age-related macular degeneration: meta-analysis of randomized controlled trials | Q34445588 |
| | Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial | Q34490891 |
| | Risk assessment for the carotenoids lutein and lycopene | Q34543564 |
| | Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study | Q34657635 |
| | Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial. | Q36792411 |
| | The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. | Q37231317 |
| | Candidate gene study of macular response to supplemental lutein and zeaxanthin | Q37286511 |
| | Preliminary analysis of the relationship between serum lutein and zeaxanthin levels and macular pigment optical density | Q37395594 |
| | Relationship between macular pigment and visual function in subjects with early age-related macular degeneration | Q37627233 |
| | The role of macular pigment assessment in clinical practice: a review. | Q37772536 |
| | A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration | Q37961646 |
| | Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration | Q38009110 |
| | Mechanisms of age-related macular degeneration and therapeutic opportunities | Q38150757 |
| | Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. | Q38238059 |
| | Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial | Q38454228 |
| | Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration. | Q38636016 |
| | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. | Q38653249 |
| | Clinical imaging of macular pigment optical density and spatial distribution | Q39019340 |
| | Nitroxide free radicals protect macular carotenoids against chemical destruction (bleaching) during lipid peroxidation. | Q39191018 |
| | Relationship between macular pigment and visual acuity in eyes with early age-related macular degeneration | Q39436968 |
| | Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration | Q39575237 |
| | LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls | Q39796168 |
| | Standardized mean differences cause funnel plot distortion in publication bias assessments | Q40051493 |
| | Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model. | Q41111119 |
| | Macular pigment in donor eyes with and without AMD: a case-control study. | Q43514008 |
| | Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial | Q44696848 |
| | Foveal cone-photoreceptor integrity in aging macula disorder | Q46788914 |
| | Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial | Q47253521 |
| | Changes in macular pigment optical density and serum concentrations of lutein and zeaxanthin in response to weight loss | Q47401647 |
| | Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam® 200 pigment module: Impact of age-related macular degeneration and lens status | Q47818113 |
| | Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13. | Q48553385 |
| | Autofluorescence imaging of macular pigment: influence and correction of ocular media opacities | Q48827624 |
| | Safety assessment of lutein and zeaxanthin (Lutemax 2020): subchronic toxicity and mutagenicity studies | Q50037630 |
| | Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. | Q50268024 |
| | Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. | Q53121765 |
| | Correlations between internal and external ocular factors and macular pigment optical density. | Q54958730 |
| | Modulatory Effect of Carotenoid Supplement Constituting Lutein and Zeaxanthin (10:1) on Anti-oxidant Enzymes and Macular Pigments Level in Rats. | Q55113695 |
| | Attenuation of choroidal neovascularization by dietary intake of ω-3 long-chain polyunsaturated fatty acids and lutein in mice. | Q55225281 |
| | Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration. | Q55491304 |
| | Lutein and Zeaxanthin in the Eyes, Serum and Diet of Human Subjects | Q57255639 |
| | Lutein protects human retinal pigment epithelial cells from oxidative stress‑induced cellular senescence | Q57481853 |
| | The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis | Q58611705 |
| | Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration | Q60699438 |
| | Preliminary identification of the human macular pigment | Q69790666 |
| | The macular pigment. II. Spatial distribution in primate retinas | Q71356053 |
| | HUMAN VISION AND THE SPECTRUM | Q81013736 |
| | Effect of 1-year lutein supplementation on macular pigment optical density and visual function | Q84785294 |
| | Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial | Q85324652 |
| | Mitochondrial quality control in AMD: does mitophagy play a pivotal role? | Q88733084 |
| | Carotenoids in human nutrition and health | Q89048921 |
| | Liberation of lutein from spinach: Effects of heating time, microwave-reheating and liquefaction | Q90014309 |
| | Oxidative stress damage circumscribed to the central temporal retinal pigment epithelium in early experimental non-exudative age-related macular degeneration | Q90015985 |
| | The Potential Role of Dietary Antioxidant Capacity in Preventing Age-Related Macular Degeneration | Q90662521 |
| | Consumption of eggs and the 15-year incidence of age-related macular degeneration | Q92633830 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P921 | main subject | macular degeneration | Q27429789 |
| P304 | page(s) | e0227048 | |
| P577 | publication date | 2019-12-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Effects of lutein supplementation in age-related macular degeneration | |
| P478 | volume | 14 | |